Impact of home patient telemonitoring on use of β-blockers in congestive heart failure

Drugs and Aging

Volumn 27, Issue 10, 2010, Pages 801-805

  Antonicelli, Roberto ^a   Mazzanti, Ilaria ^a   Abbatecola, Angela M ^a   Parati, Gianfranco ^b,c  

^a INRCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Beta adrenergic receptor antagonists, therapeutic use; Heart failure, treatment.

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HOME CARE; HOME MONITORING; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TELEMONITORING;

ADRENERGIC BETA-ANTAGONISTS; AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MEDICATION ADHERENCE; MONITORING, AMBULATORY; PATIENT CARE TEAM; PATIENT READMISSION; TELEMEDICINE;

EID: 77957727064     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11538210-000000000-00000     Document Type: Article

References (20)

1. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Utiliza-tion Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-9
2. Garg RG, Yusuf S. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbilityin patients with heart failure. JAMA 1995; 273: 1540-6
3. Swedberg K, Hjalmason A, Waagstein F, et al. Prolongation of survival in congestive cardiomyopathy by beta-block-ade. Lancet 1979; I: 1374-6
4. Swedberg K, Hjalmarson A, Waagstein F, et al. Beneficial effects of long term beta-blockade in congestive cardio-myopathy. Br Heart J 1980; 44: 117-33
5. Effect ofmetoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial. Lancet 1999; 353: 9-13
7. Colucci WS, Paker M, Bristow MR, et al., US Carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild symptoms of heart fail-ure. Circulation 1996; 94: 2800-6
8. Parker M, Colucci WS, Sackner-Bernstein JD, et al., PRECISE Study Group. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the Prospective Randomized Evalu-tation ofCarvedilol in Symptoms and Exercise (PRECISE) trial. Circulation 1996; 94: 2793-9
9. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8
10. Yancy CW, Fowler MB, Colucci WS, et al. Race and response to adrenergic blockade with carvedilol in patients withchronicheartfailure.NEngl JMed2001; 344: 1358-65
11. Krum H, Haas SJ, Eichhorn E, et al. Prognostic benefit of beta-blockers in patients not receiving ACE-inhibitors. Eur Heart J 2005; 26: 2154-8
12. Chan JD, Rea TD, Smith NL, et al. Association of betablocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS). Am Heart J 2005; 150: 464-70
13. Lopez-Sendon J, Swedberg K, McMurray J, et al. Task Force on Beta-Blockers of the European Society ofCardiology Expert consensus document on betaadrenergic receptor blockers. Eur Heart J 2004 Aug; 25 (15): 1341-62
14. Dargie HJ. Effect ofcarvedilol on outcome after myocardial infarction patients with left-ventricular dysfunction: the CAPRICORNrandomisedtrial. Lancet2001; 357:1385-90
15. Maggioni AP, Sinagra G, Opasich C, et al., Beta Blockers in Patients with Congestive Heart Failure: Guided Use in Clini-cal Practice Investigators. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 2003 Mar; 89 (3): 299-305
16. OpasichC, Boccanelli A, Cafiero M, et al., BRING-UP 2Investigators. Programme to improve the use ofbeta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 study. Eur J Heart Fail 2006 Oct; 8 (6): 649-57
17. Krum H, Hill J, Fruhwald F, et al. Tolerability of betablockers in elderly patients with chronic heart failure: the COLA II study. Eur J Heart Fail 2006 May; 8 (3): 302-7
18. Spaeder J, Najjar SS, Gerstenblith G, et al. Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. Am Heart J 2006 Apr; 151 (4): 844.e1-10
19. Moyer-Knox D, Mueller TM, Vuckovic K, et al. Remote titration ofcarvedilol for heart failure patients by advanced practice nurses. J Card Fail 2004 Jun; 10 (3): 219-24
20. Antonicelli R, Testarmata P, Spazzafumo L, et al. Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare 2008; 14: 300-5